The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies.
Categories:
Related Post
Balfour Beatty plans stateside AI hackathon
Following on its push in the U.K., the firm’s American initiative will target solutions for…
ICE raids leave future of construction labor in limbo
Increased immigration enforcement on jobsites has led to more callouts and potentially longer project timelines, but experts believe…
Hensel Phelps starts 2026 with new CEO
Brad Jeanneret, formerly the COO, will step into the role as Mike Choutka transitions to…